5. HISTORICAL BACKGROUND
In 1923 GOTTLIEB reported a fatal case of
influenza and called it as
“ diffuse atrophy of the alveolar bone ”
characterized by :
-- loss of collagen fibers
-- extensive bone loss
-- widened pdl space
6. In 1928 GOTTLIEB attributed this condition to
inhibition of continuous cementum formation,
which he termed the disease as
“deep cementopathia ”
7. In 1938 WANNENMACHER described incisor-first- molar
involvement and called the disease
“ parodontitis marginalis progressiva ”
He considered it as inflammatory process
8. In 1940 THOMA AND GOLDMAN
referred this disease as
“ paradontosis ”
The initial abnormality was located in the
al.bone rather then in the cementum
9. IN 1942 ORBAN AND WEINMANN
introduced the term
“ periodontosis ”
THREE STAGES
STAGE I
STAGE II
STAGE III
10. STAGE I :
degeneration of principal fibers of pdl
cessation of cementum formation
resorption of the alveolar bone
STAGE II :
rapid proliferation of the JE
earliest signs of inflammation
STAGE III :
progressive inflammation
deep, infrabony periodontal pockets
11. DEFINITION
BAER - 1971
“a disease of periodontium occurring in an
otherwise healthy adolescents which is characterized
by a rapid loss of alveolar bone about more than
one tooth of permanent dentition”
12. PREVELENCE
BAER
U.S POPULATION -- 0.1%
SAXBY
ENGLISH POPULATION -- 0.1%
MIGLANI
ASIAN POPULATION -- 0.1%
SAXEN
FRENCH POPULATION -- 0.1%
13. AGE AND SEX DISTRIBUTION
PUBERTY -- 21 Yrs OF AGE
MORE PREDILICTION FOR FEMALES
FEMALE : MALE = 3.5 : 1
14. DISTRIBUTION OF LESIONS
Classic distribution -- molar and incisors
Least distribution -- cuspid and premolars
THREE TYPES :
1. First molars and incisors
2. First molars and incisors and some
additional teeth [total of < 14 teeth ]
3. Generalized involvement
15. POSSIBLE REASONS FOR THE LIMITATIONS OF
PERIODONTAL DESTRUCTION TO 1st MOLARS AND
INCISORS ARE:
1] After initial colonisation of 1st per.molar and
incisors Aa bacilli are phagocytosed by
immune defenses [NEUTROPHILES, MONOCYTES] and
neutralize destructive factors. [ENDOTOXIN,
LEUCOTOXIN, COLLAGENASE]
16. 2]Antagonist to Aa may develop there by
decreasing the destruction of the lesions
3] Aa may loose its leukotoxin producing
ability for unknown reasons. when this
happens the progress of the disease may
become
arrested
17. CLINICAL FINDINGS
1] The most striking feature of early Lap
is lack of clinical inflammation, despite the
presence of deep periodontal pockets
2] There may be a small amount of plaque,
which forms a thin film on tooth and rarely
mineralizes to become calculus
18. 3] Disto-labial migration of max. incisors,
with diastema formation
4] Root surfaces become sensitive to thermal
and tactile stimuli
5] Deep, dull radiating pain may occur with
mastication
19.
20. RADIOGRAPHIC FINDINGS
1] Vertical loss of alveolar bone around the
1st molars and incisors in healthy teenagers is
a diagnostic sign of classic lap
2] Arc- shaped bone loss extending from the
distal surface of second pm -- mesial surface of
2nd molar
21. 3] Resorption of roots of 1st molar and incisors
4] Bilaterally symmetrical type of bone loss
resembling that of “ mirror images ”
22. CLINICAL COURSE
Lap progresses rapidly and rate of bone loss
is about 3- 4 times faster than in periodontitis
Bone resorption progresses until the
teeth are treated, exfoliated or extracted which
is termed as “ burn out” phenomenon
26. GENERALIZED AGGRESSIVE PERIODONTITIS
CLINICAL FEATURES
under the age of 30 years
poor antibody response to the pathogens
generalized interproximal attachment loss
affecting at least three permanent teeth
other than first molars and incisors
27. occur episodically with periods of advanced
destruction followed by periods of quiescence
small amounts of bacterial plaque associated
with affected
teeth
28. TWO GINGIVAL TISSUE RESPONSES
ONE IS
severe, acutely inflamed, fiery red,
proliferating, ulcerated tissue
bleeding occur spontaneously
suppuration
29. SECOND IS
gingival tissues appear pink,
free of inflammation
despite mild clinical appearance,
deep pockets can be probed
32. PREVALENCE / AGE AND SEX DISTRIBUTUON
SRILANKA -- 8%
U.S ADOLESCENTS AGED 14 -17 yrs -- 0.13%
BLACKS -- HIGHER RISK > WHITES
MALES -- MORE LIKELY > FEMALES
33. ETIOLOGY: [RISK FACTORS]
1. HEREDITY
Baer described the disease in twins, siblings
and first cousins as well as in parents and offspring
Transmitted as x- linked dominant disease
[if the father and mother has AP sons and daughters
has AP ]
35. TWO CLASSIFICATIONS
1ST CLASSIFICATION
GRAM – VE
1 Aa
2 capnocytophaga sub- species sputegena
3 Motile anaerobic rods
a, spirochetes b,mycoplasma
c,ekenella d,wolionella
e, black pigmented bacteroids
GRAM + VE
1 streptococcus
2 pepto streptococcus
37. 3. IMMUNOLOGY
Functional defects of PMNs and monocytes
These defects can impair :
Chemo tactic attraction of PMNs to the site
Phagocytosis of microorganisms
39. i LEUKOTOXIN:
Destroys PMNs and monocytes there by inhibit
host defense
mechanism
ii ENDOTOXIN: [LPS]
Stimulate osteoclast -- bone resorption
iii COLLAGENASE:
Destroys gingival CT [collagen]
iv EPITHELIOTOXIN:
Facilitates penetration of Aa into CT through JE
and destroy collagen
40. v FIBROBLAST INHIBITING FACTOR:
Impair collagen formation
vi OSTEOCLAST ACTIVATING FACTOR [ OAF ] :
Brings about resorption of Al. bone
vii POLYCONAL B-LYMPHOCYTE ACTIVATING FACTOR:
Mediate inflammatory reaction by stimulating OAF
and bring about bone resorption
41. 5. ENVIRONMENTAL FACTORS
Patients with GAP who smoke have more affected teeth
and loss of clinical attachment than non smokers
Smoking may not have the same impact on patients with LAP